| Title |
Hepatitis B virus management to prevent reactivation after chemotherapy: a review
|
|---|---|
| Published in |
Supportive Care in Cancer, August 2012
|
| DOI | 10.1007/s00520-012-1576-7 |
| Pubmed ID | |
| Authors |
Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey, Rohit Loomba |
| Abstract |
Reactivation of hepatitis B virus (HBV) infection after chemotherapy can lead to liver failure and death. Conflicting recommendations regarding HBV screening in cancer patients awaiting chemotherapy mean that some patients at risk for HBV reactivation are not being identified and treated with prophylactic antiviral therapy. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 6% |
| United States | 2 | 4% |
| Unknown | 49 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 30% |
| Student > Ph. D. Student | 6 | 11% |
| Student > Master | 5 | 9% |
| Student > Doctoral Student | 5 | 9% |
| Other | 4 | 7% |
| Other | 11 | 20% |
| Unknown | 7 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 56% |
| Agricultural and Biological Sciences | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Nursing and Health Professions | 2 | 4% |
| Psychology | 2 | 4% |
| Other | 5 | 9% |
| Unknown | 9 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2012.
All research outputs
#15,911,990
of 24,417,958 outputs
Outputs from Supportive Care in Cancer
#3,147
of 4,891 outputs
Outputs of similar age
#107,177
of 172,633 outputs
Outputs of similar age from Supportive Care in Cancer
#31
of 42 outputs
Altmetric has tracked 24,417,958 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,891 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,633 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.